Quantitative and qualitative alterations of platelet, erythrocytes, leukocytes and endothelial cells, caused by gain-of-function mutations in JAK2, CALR or MPL, are implicated in the pathogenesis of thrombosis in MPN [45,48]. The gene discussed is CALR; the disease is myeloproliferative neoplasm.